As a transplant surgeon, my goal is to provide high quality, comprehensive medical and surgical care for patients as they transition from end-stage organ disease to life after transplantation. I am committed to developing and applying novel new strategies to permit transplantation in patients with antibody incompatibilities who have previously been unable to benefit from improvements in the quality and duration of life that result from transplantation. Outstanding care of the end-stage organ disease patient mandates a multidisciplinary approach to their management. I am confident that we have a team that can address all of the issues that arise in these complex patients after organ transplantation.